Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $1.25 Million - $1.62 Million
-31,200 Reduced 82.98%
6,400 $256,000
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $1.25 Million - $1.64 Million
34,300 Added 1039.39%
37,600 $1.79 Million
Q1 2024

May 15, 2024

SELL
$42.03 - $53.55 $222,759 - $283,815
-5,300 Reduced 61.63%
3,300 $143,000
Q4 2023

Feb 14, 2024

SELL
$43.39 - $51.63 $564,070 - $671,190
-13,000 Reduced 60.19%
8,600 $435,000
Q3 2023

Nov 14, 2023

SELL
$38.5 - $47.13 $311,850 - $381,753
-8,100 Reduced 27.27%
21,600 $979,000
Q2 2023

Aug 14, 2023

BUY
$34.73 - $43.33 $340,353 - $424,634
9,800 Added 49.25%
29,700 $1.22 Million
Q1 2023

May 15, 2023

BUY
$33.58 - $41.2 $668,242 - $819,880
19,900 New
19,900 $711,000
Q1 2020

May 15, 2020

SELL
$41.6 - $63.4 $4,160 - $6,340
-100 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$53.85 - $65.27 $43,080 - $52,216
-800 Reduced 88.89%
100 $6,000
Q3 2019

Nov 14, 2019

SELL
$59.06 - $72.15 $124,026 - $151,515
-2,100 Reduced 70.0%
900 $54,000
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $149,016 - $206,736
2,400 Added 400.0%
3,000 $193,000
Q1 2019

May 15, 2019

BUY
$52.92 - $81.17 $31,752 - $48,702
600 New
600 $49,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.